A Comparative Cost-Effectiveness Analysis of Percutaneous Transluminal Angioplasty With Optional Stenting and Femoropopliteal Bypass Surgery for Medium-Length TASC II B and C Femoropopliteal Lesions.
Rianne J VossenPilar C PhilipszoonAnco C VahlAlexander D Montauban van SwijndregtVanessa J LeijdekkersRon BalmPublished in: Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists (2020)
FPB in medium-length femoropopliteal lesions involved higher total costs when evaluated over a 3-year follow-up period. An endovascular-first approach is recommended, as this will result in cost minimization for patients with medium-length femoropopliteal disease.